Net Cash Provided by (Used in) Financing Activities of RxSight, Inc. from 31 Dec 2020 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
RxSight, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
  • RxSight, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $735,000, a 109% decline year-over-year.
  • RxSight, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $1,863,000, a 98% decline from 2024.
  • RxSight, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $123,319,000, a 100% increase from 2023.
  • RxSight, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $61,524,000, a 872% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

RxSight, Inc. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $1,863,000 -$121,456,000 -98% 01 Jan 2025 31 Dec 2025 10-K 25 Feb 2026 2025 FY
2024 $123,319,000 +$61,795,000 +100% 01 Jan 2024 31 Dec 2024 10-K 25 Feb 2026 2025 FY
2023 $61,524,000 +$55,192,000 +872% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2026 2025 FY
2022 $6,332,000 -$131,010,000 -95% 01 Jan 2022 31 Dec 2022 10-K 25 Feb 2025 2024 FY
2021 $137,342,000 +$112,105,000 +444% 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023 2022 FY
2020 $25,237,000 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022 2021 FY

RxSight, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $735,000 -$8,727,000 -109% 01 Jan 2025 31 Mar 2025 10-Q 07 May 2025 2025 Q1
Q1 2024 $7,992,000 -$57,313,000 -88% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2025 2025 Q1
Q1 2023 $65,305,000 +$65,403,000 01 Jan 2023 31 Mar 2023 10-Q 06 May 2024 2024 Q1
Q1 2022 $98,000 -$6,242,000 -102% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q1 2021 $6,144,000 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.